Persist AI
10× Faster Formulation Discovery with AI + Robotics
Persist AI combines artificial intelligence and robotic lab automation to accelerate pharmaceutical formulation development, including long-acting injectables, amorphous solid dispersions, and parenterals. The platform offers three tiers of service: a self-improving AI suite deployed on the customer's cloud, a cloud lab where users design experiments executed by robots, and a full-service offering where Persist handles design, execution, and optimization end to end. The company claims up to 10x faster formulation discovery compared to industry standards.
Persist AI uses AI-guided experimental design combined with robotic lab execution to rapidly iterate and optimize drug formulations, streaming results to a user dashboard.
pharmaceutical and biotech companies seeking faster drug formulation development
Background.
- Status
- launched
- Business model
- unknown
- Company
- Persist AI
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.